Compression chamberTraining sessions on basic life support always relax a bit once everyone’s had a go at chest […]
Summary boxClinical context—Sarcopenia is defined as age related loss of muscle mass and function and is associated with […]
Strategies to end the pandemicRather than trying to beat SARS-CoV-2 using one booster vaccine at a time, it […]
Rachel Levine’s appointment to the senior ranks of US healthcare was global news in 2021 when the paediatrician […]
If we are going to learn to live with covid, then we need to listen to people living with ill health
Like last January, infection rates of covid-19 are rising, followed by rising hospital admissions, cancellations of non covid […]
AstraZeneca (AZ) has reported preliminary data from a trial it conducted on its COVID-19 booster shot, Vaxzevria.
Despite diagnosis and treatment options improving for the rare kidney condition, further action is urgently required.
Updated Date: Wed, 05 Jan 2022 00:00:00 EST
Updated Date: Wed, 05 Jan 2022 00:00:00 EST
Updated Date: Wed, 05 Jan 2022 00:00:00 EST